|
🐜
|
Radiation exposure of patients undergoing whole-body dual-modality 18F-FDG PET/CT examinations.
7 auth.
G. Brix,
U. Lechel,
G. Glatting,
S. Ziegler,
W. Münzing,
S. Müller,
...
T. Beyer
|
8 |
2005 |
8
🐜
|
|
🐜
|
Acquisition protocol considerations for combined PET/CT imaging.
7 auth.
T. Beyer,
G. Antoch,
S. Müller,
T. Egelhof,
L. Freudenberg,
J. Debatin,
...
A. Bockisch
|
7 |
2004 |
7
🐜
|
|
🐜
|
Differentiated thyroid cancer: Impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration (stage pT4)
7 auth.
J. Farahati,
C. Reiners,
M. Stuschke,
S. Müller,
G. Stüben,
W. Sauerwein,
...
H. Sack
|
7 |
1996 |
7
🐜
|
|
🐜
|
Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas (PETAL): A Multicenter, Randomized Phase III Trial.
45 auth.
U. Dührsen,
S. Müller,
B. Hertenstein,
H. Thomssen,
J. Kotzerke,
R. Mesters,
W. Berdel,
C. Franzius,
F. Kroschinsky,
M. Weckesser,
D. Kofahl-Krause,
F. Bengel,
J. Dürig,
J. Matschke,
C. Schmitz,
...
T. Pöppel,
C. Ose,
M. Brinkmann,
P. La Rosée,
M. Freesmeyer,
A. Hertel,
H. Höffkes,
D. Behringer,
G. Prange‐Krex,
S. Wilop,
T. Krohn,
J. Holzinger,
M. Griesshammer,
Aristoteles A N Giagounidis,
A. Raghavachar,
G. Maschmeyer,
I. Brink,
H. Bernhard,
U. Haberkorn,
T. Gaska,
L. Kurch,
D. V. van Assema,
W. Klapper,
D. Hoelzer,
L. Geworski,
K. Jöckel,
A. Scherag,
A. Bockisch,
J. Rekowski,
A. Hüttmann
|
7 |
2018 |
7
🐜
|
|
🐢
|
Positron emission tomography/computed tomography--imaging protocols, artifacts, and pitfalls.
7 auth.
A. Bockisch,
T. Beyer,
G. Antoch,
L. Freudenberg,
H. Kühl,
J. Debatin,
...
S. Müller
|
7 |
2004 |
7
🐢
|
|
🐜
|
MR-based attenuation correction for torso-PET/MR imaging: pitfalls in mapping MR to CT data
9 auth.
T. Beyer,
Markus Weigert,
H. Quick,
U. Pietrzyk,
F. Vogt,
C. Palm,
...
G. Antoch,
S. Müller,
A. Bockisch
|
6 |
2008 |
6
🐜
|
|
🐜
|
Value of 124I-PET/CT in staging of patients with differentiated thyroid cancer
10 auth.
L. Freudenberg,
G. Antoch,
W. Jentzen,
R. Pink,
J. Knust,
R. Görges,
...
S. Müller,
A. Bockisch,
J. Debatin,
W. Brandau
|
6 |
2004 |
6
🐜
|
|
🐜
|
Dynamic risk assessment based on positron emission tomography scanning in diffuse large B-cell lymphoma: Post-hoc analysis from the PETAL trial.
9 auth.
C. Schmitz,
A. Hüttmann,
S. Müller,
M. Hanoun,
R. Boellaard,
M. Brinkmann,
...
K. Jöckel,
U. Dührsen,
J. Rekowski
|
6 |
2019 |
6
🐜
|
|
🐜
|
Comparison of FDG-PET/CT and bone scintigraphy for detection of bone metastases in breast cancer
11 auth.
S. Hahn,
T. Heusner,
S. Kümmel,
A. Köninger,
J. Nagarajah,
S. Müller,
...
C. Boy,
M. Forsting,
A. Bockisch,
G. Antoch,
A. Stahl
|
6 |
2011 |
6
🐜
|
|
🐬
|
The value of fluorine-18 fluorodeoxyglucose positron emission tomography in patients with medullary thyroid cancer
K. Brandt-Mainz,
S. Müller,
R. Görges,
B. Saller,
A. Bockisch
|
5 |
2000 |
5
🐬
|
